رجوع
نطاق اليوم
KWD 13.43
KWD 14.08
نطاق 52 أسبوعًا
KWD 7.98
KWD 19.51
حجم التداول
71,507
متوسط 50 يوم / 200 يوم
KWD 15.62
/
KWD 14.17
الإغلاق السابق
KWD 13.39
Quick Summary
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (631 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -17.6 | 0.3 |
| P/B | 3.0 | 3.0 |
| ROE % | -21.0 | 3.7 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 36.50
+167.4%
Low: KWD 32.00
High: KWD 40.00
ربحية السهم المستقبلية
-KWD 1.46
الإيرادات المقدّرة
0.0
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 0.17
KWD 0.17 – KWD 0.17
|
345.68M | 5 |
| FY2029 |
-KWD 1.60
-KWD 1.60 – -KWD 1.60
|
91.25M | 2 |
| FY2028 |
-KWD 2.18
-KWD 3.34 – -KWD 1.54
|
5.06M | 7 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-05 | -KWD 0.26 | -KWD 0.23 | +13.0% |
| 2025-11-06 | -KWD 0.23 | -KWD 0.23 | 0.0% |
| 2025-08-07 | -KWD 0.22 | -KWD 0.15 | +31.8% |
| 2025-05-08 | -KWD 0.61 | -KWD 0.19 | +68.9% |
| 2025-02-27 | -KWD 0.23 | -KWD 0.17 | +26.1% |
| 2024-11-14 | -KWD 0.25 | -KWD 0.23 | +8.0% |
| 2024-09-03 | -KWD 0.23 | -KWD 0.20 | +13.0% |
| 2024-05-03 | -KWD 0.22 | -KWD 0.15 | +31.8% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
النقاط الرئيسية
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -43.67M
النمو
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-21.04%
ROIC-16.24%
Net MarginN/A
Op. MarginN/A
الأمان
Debt / Equity
0.00
Current Ratio34.13
Interest Coverage-131.05
التقييم
P/E Ratio
-17.55
Forward P/EN/A
P/B Ratio3.03
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -48.26M |
| ROE | -21.04% | ROA | -16.74% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -43.67M |
| ROIC | -16.24% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 34.13 |
| Interest Coverage | -131.05 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -17.55 | Forward P/E | N/A |
| P/B Ratio | 3.03 | P/S Ratio | N/A |
| PEG Ratio | -3.01 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -5.16% | ||
| Market Cap | 846.70M | Enterprise Value | 600.96M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -48.26M | -38.96M | -35.59M | -22.46M | -9.20M |
| EPS (Diluted) | -0.79 | -0.75 | -0.68 | -0.14 | -0.18 |
| Gross Profit | -335,000.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -60.68M | -50.31M | -41.22M | -30.55M | -15.10M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 288.23M | 188.27M | 226.30M | 254.36M | 279.92M |
| Total Liabilities | 8.53M | 9.32M | 7.33M | 4.55M | 2.75M |
| Shareholders' Equity | 279.70M | 178.95M | 218.97M | 249.82M | 277.18M |
| Total Debt | 512,000.0 | 624,000.0 | 974,000.0 | 0.0 | 0.0 |
| Cash & Equivalents | 246.25M | 100.79M | 78.42M | 165.96M | 276.78M |
| Current Assets | 285.98M | 154.23M | 164.09M | 168.54M | 279.84M |
| Current Liabilities | 8.38M | 8.95M | 6.70M | 4.55M | 2.75M |